{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:20:28Z","timestamp":1784384428347,"version":"3.55.0"},"reference-count":128,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Periprocedural myocardial infarction (PMI) and injury, pertinent to both cardiac and non-cardiac procedures, have gained increasing recognition in clinical practice. Over time, diverse definitions for diagnosing PMI have been developed and validated among patient populations undergoing coronary revascularization. However, this variety in definitions presents considerable challenges in clinical settings and complicates both the design and interpretation of clinical trials. The necessity to accurately diagnose PMI has spurred significant interest in establishing universally accepted and prognostically meaningful thresholds for cardiac biomarkers elevation and supportive ancillary criteria. In fact, elevations in cardiac biomarkers in line with the 4th Universal Definition of Myocardial Infarction, have been extensively confirmed to be associated with increased mortality and cardiovascular events. In the context of non-coronary cardiac procedures, such as Transcatheter Aortic Valve Implantation, there is a growing acknowledgment of both the high incidence rates and the adverse impact of PMI on patient outcomes. Similarly, emerging research underscores the significance of PMI and injury in non-cardiac surgery, highlighting the urgent need for effective prevention and risk management strategies in this domain.<\/jats:p>","DOI":"10.1093\/ehjacc\/zuae014","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T13:15:34Z","timestamp":1707225334000},"page":"433-445","source":"Crossref","is-referenced-by-count":19,"title":["Periprocedural myocardial infarction and injury"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5434-607X","authenticated-orcid":false,"given":"Marco","family":"Spagnolo","sequence":"first","affiliation":[{"name":"Division of Cardiology, A.O.U. Policlinico \u2018G. Rodolico\u2014San Marco\u2019, University of Catania , Via Santa Sofia 78, Catania - 95123 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0157-7242","authenticated-orcid":false,"given":"Giovanni","family":"Occhipinti","sequence":"additional","affiliation":[{"name":"Division of Cardiology, A.O.U. Policlinico \u2018G. Rodolico\u2014San Marco\u2019, University of Catania , Via Santa Sofia 78, Catania - 95123 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5467-7402","authenticated-orcid":false,"given":"Claudio","family":"Laudani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, A.O.U. Policlinico \u2018G. Rodolico\u2014San Marco\u2019, University of Catania , Via Santa Sofia 78, Catania - 95123 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2926-9428","authenticated-orcid":false,"given":"Antonio","family":"Greco","sequence":"additional","affiliation":[{"name":"Division of Cardiology, A.O.U. Policlinico \u2018G. Rodolico\u2014San Marco\u2019, University of Catania , Via Santa Sofia 78, Catania - 95123 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-7723","authenticated-orcid":false,"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[{"name":"Division of Cardiology, A.O.U. Policlinico \u2018G. Rodolico\u2014San Marco\u2019, University of Catania , Via Santa Sofia 78, Catania - 95123 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"2024052816272982500_zuae014-B1","doi-asserted-by":"crossref","first-page":"e015317","DOI":"10.1161\/JAHA.119.015317","article-title":"Temporal trends in percutaneous coronary intervention and coronary artery bypass grafting: insights from the Washington cardiac care outcomes assessment program","volume":"9","author":"Kataruka","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2024052816272982500_zuae014-B2","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjcard.2021.08.018","article-title":"In-Hospital mortality for inpatient percutaneous coronary interventions in the United States","volume":"159","author":"Chang","year":"2021","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jcin.2019.04.015","article-title":"Incidence, predictors, and outcomes of acute ischemic stroke following percutaneous coronary intervention","volume":"12","author":"Alkhouli","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jacc.2021.11.047","article-title":"Frequency and outcomes of periprocedural MI in patients with chronic coronary syndromes undergoing PCI","volume":"79:","author":"Ueki","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B6","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2010.12.005","article-title":"Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium","volume":"57","author":"Leon","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B8","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/eurheartj\/ehab271","article-title":"Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a consensus document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"42","author":"Bulluck","year":"2021","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-154-8-201104190-00003","article-title":"Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study","volume":"154","author":"Devereaux","year":"2011","journal-title":"Ann Intern Med"},{"key":"2024052816272982500_zuae014-B10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcin.2023.03.022","article-title":"Myocardial injury after transcatheter aortic valve replacement according to VARC-3 criteria","volume":"16","author":"Real","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized End point definitions for coronary intervention trials: the academic research consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B13","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2020.08.016","article-title":"Implications of alternative definitions of peri-procedural myocardial infarction after coronary revascularization","volume":"76","author":"Gregson","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.amjcard.2013.12.016","article-title":"Impact of the angiographic mechanisms underlying periprocedural myocardial infarction after drug-eluting stent implantation","volume":"113","author":"Park","year":"2014","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcin.2015.01.032","article-title":"Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY trial (Coronary Assessment by Near-Infrared of Atherosclerotic Rupture-Prone Yellow)","volume":"8","author":"Stone","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B17","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/eht048","article-title":"Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention","volume":"34","author":"Park","year":"2013","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCINTERVENTIONS.112.969089","article-title":"Carina shift versus plaque shift for aggravation of side branch ostial stenosis in bifurcation lesions: volumetric intravascular ultrasound analysis of both branches","volume":"5","author":"Xu","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ccd.1810360406","article-title":"Coronary air embolism: incidence, severity, and suggested approaches to treatment","volume":"36:","author":"Khan","year":"1995","journal-title":"Cathet Cardiovasc Diagn"},{"key":"2024052816272982500_zuae014-B20","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.amjcard.2019.07.021","article-title":"Prevalence and predictors of coronary artery perforation during percutaneous coronary interventions (from the ORPKI national registry in Poland)","volume":"124","author":"Rakowski","year":"2019","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B21","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.25270\/jic\/21.00376","article-title":"Outcomes after early postoperative myocardial infarction due to graft failure in patients undergoing coronary artery bypass grafting","volume":"35","author":"Baumgarten","year":"2023","journal-title":"J Invasive Cardiol"},{"key":"2024052816272982500_zuae014-B22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ejcts.2005.06.048","article-title":"Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role?","volume":"28","author":"Fujii","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024052816272982500_zuae014-B23","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/eurheartj\/ehx383","article-title":"ESC joint working groups on cardiovascular surgery and the cellular biology of the heart position paper: perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery","volume":"38","author":"Thielmann","year":"2017","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0009-8981(98)00047-3","article-title":"Differentiation between transmural perioperative myocardial infarction and subendocardial injury after coronary artery bypass grafting using biochemical tests, elaborated by cluster and discriminant analysis","volume":"274","author":"Harff","year":"1998","journal-title":"Clin Chim Acta"},{"key":"2024052816272982500_zuae014-B25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehac604","article-title":"Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications","volume":"44","author":"Heuts","year":"2023","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.carrev.2017.01.008","article-title":"Troponin I elevation and all-cause mortality after elective percutaneous coronary interventions","volume":"18","author":"Ferreira","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"2024052816272982500_zuae014-B27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurheartj\/ehaa885","article-title":"Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data","volume":"42","author":"Silvain","year":"2021","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B28","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jcin.2021.05.006","article-title":"Implications of periprocedural myocardial biomarker elevations and commonly used MI definitions after left main PCI","volume":"14","author":"Wang","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa2000803","article-title":"High-Sensitivity troponin I after cardiac surgery and 30-day mortality","volume":"386","author":"Devereaux","year":"2022","journal-title":"N Engl J Med"},{"key":"2024052816272982500_zuae014-B30","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/eurheartj\/ehac054","article-title":"Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis","volume":"43","author":"Polzl","year":"2022","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.2011.99","article-title":"Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery","volume":"305","author":"Domanski","year":"2011","journal-title":"JAMA"},{"key":"2024052816272982500_zuae014-B32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","article-title":"Periprocedural myocardial infarction and injury in elective coronary stenting","volume":"39","author":"Zeitouni","year":"2018","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B33","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jcin.2019.07.014","article-title":"Impact of periprocedural myocardial biomarker elevation on mortality following elective percutaneous coronary intervention","volume":"12","author":"Garcia-Garcia","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B34","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2006.04.102","article-title":"Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality","volume":"48","author":"Prasad","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1536\/ihj.22-475","article-title":"Association of Pre-procedural nutritional indicators with periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention","volume":"64","author":"Liu","year":"2023","journal-title":"Int Heart J"},{"key":"2024052816272982500_zuae014-B36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/ehjci\/jead025","article-title":"Coronary CT angiography-derived plaque characteristics and physiologic patterns for peri-procedural myocardial infarction and subsequent events","volume":"24","author":"Dai","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024052816272982500_zuae014-B37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12968-023-00916-1","article-title":"Relationship between coronary high-intensity plaques on T1-weighted imaging by cardiovascular magnetic resonance and vulnerable plaque features by near-infrared spectroscopy and intravascular ultrasound: a prospective cohort study","volume":"25","author":"Fukase","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024052816272982500_zuae014-B38","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B40","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","article-title":"Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ahj.2009.07.029","article-title":"Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies","volume":"158","author":"Davlouros","year":"2009","journal-title":"Am Heart J"},{"key":"2024052816272982500_zuae014-B42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage During Angioplasty) study","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B43","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1016\/j.ijcard.2013.06.017","article-title":"Comparison of high reloading ROsuvastatin and atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial","volume":"168","author":"Sardella","year":"2013","journal-title":"Int J Cardiol"},{"key":"2024052816272982500_zuae014-B44","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2009.07.005","article-title":"Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction","volume":"54","author":"Briguori","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjcard.2013.10.026","article-title":"Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study)","volume":"113","author":"Veselka","year":"2014","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B46","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"2024052816272982500_zuae014-B47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.108.809723","article-title":"Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial","volume":"119","author":"Hoole","year":"2009","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B48","doi-asserted-by":"crossref","first-page":"e115500","DOI":"10.1371\/journal.pone.0115500","article-title":"Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials","volume":"9","author":"Pei","year":"2014","journal-title":"PLoS One"},{"key":"2024052816272982500_zuae014-B49","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/ccd.24443","article-title":"Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial","volume":"81","author":"Prasad","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B50","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/nu12082199","article-title":"Vitamin C for cardiac protection during percutaneous coronary intervention: a systematic review of randomized controlled trials","volume":"12","author":"Khan","year":"2020","journal-title":"Nutrients"},{"key":"2024052816272982500_zuae014-B51","doi-asserted-by":"crossref","first-page":"e008717","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of acute colchicine administration prior to percutaneous coronary intervention","volume":"13","author":"Shah","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B52","doi-asserted-by":"crossref","first-page":"e009992","DOI":"10.1161\/CIRCINTERVENTIONS.120.009992","article-title":"Colchicine to prevent periprocedural myocardial injury in percutaneous coronary intervention: the COPE-PCI pilot trial","volume":"14","author":"Cole","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ccd.30749","article-title":"Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention","volume":"102","author":"Piccolo","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ccd.30696","article-title":"Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry","volume":"102","author":"de Filippo","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B55","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data","volume":"382","author":"Steg","year":"2013","journal-title":"Lancet"},{"key":"2024052816272982500_zuae014-B56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2018.02.008","article-title":"Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban","volume":"164","author":"Verdoia","year":"2018","journal-title":"Thromb Res"},{"key":"2024052816272982500_zuae014-B57","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ccd.25864","article-title":"Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents\u2013the PETITION study: a prospective, randomized, multicenter study","volume":"85","author":"Zhang","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B58","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","article-title":"Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and\/or resistance to clopidogrel study","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B60","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacc.2012.11.025","article-title":"Intracoronary EnalaPrilat to reduce MICROvascular damage during percutaneous coronary intervention (ProMicro) study","volume":"61","author":"Mangiacapra","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B61","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"2024052816272982500_zuae014-B62","first-page":"1","article-title":"PCSK9 inhibitors: current status and emerging frontiers in lipid control","author":"Agnello","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2024052816272982500_zuae014-B63","doi-asserted-by":"crossref","first-page":"e072541","DOI":"10.1136\/bmjopen-2023-072541","article-title":"Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial","volume":"13","author":"Huang","year":"2023","journal-title":"BMJ Open"},{"key":"2024052816272982500_zuae014-B64","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.amjcard.2018.07.040","article-title":"Meta-Analysis of the impact of strut thickness on outcomes in patients with drug-eluting stents in a coronary artery","volume":"122","author":"Iantorno","year":"2018","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B65","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jacc.2007.11.059","article-title":"Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation","volume":"51","author":"Cuisset","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B66","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1093\/eurheartj\/ehy285","article-title":"Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European association of percutaneous cardiovascular interventions","volume":"39","author":"Raber","year":"2018","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B67","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcin.2015.03.016","article-title":"Multimodality intravascular imaging to predict periprocedural myocardial infarction during percutaneous coronary intervention","volume":"8","author":"Kini","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B68","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cjca.2023.06.005","article-title":"Complementary roles of near-infrared spectroscopy and intravascular ultrasound in the prediction of periprocedural myocardial injury","volume":"39","author":"Irie","year":"2023","journal-title":"Can J Cardiol"},{"key":"2024052816272982500_zuae014-B69","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jcin.2018.04.033","article-title":"Benefit of distal protection during percutaneous coronary intervention in properly selected patients","volume":"11","author":"Kubo","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semtcvs.2020.09.010","article-title":"Skeletonized or pedicled harvesting of left internal mammary artery: a systematic review and meta-analysis","volume":"33","author":"Kusu-Orkar","year":"2021","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2024052816272982500_zuae014-B71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12265-018-9832-y","article-title":"Does No-touch technique better than conventional or intermediate saphenous vein harvest techniques for coronary artery bypass graft surgery: a systematic review and meta-analysis","volume":"11","author":"Elshafay","year":"2018","journal-title":"J Cardiovasc Transl Res"},{"key":"2024052816272982500_zuae014-B72","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.hlc.2020.10.016","article-title":"Myocardial protection in adult cardiac surgery with del nido versus blood cardioplegia: a systematic review and meta-analysis","volume":"30","author":"Misra","year":"2021","journal-title":"Heart Lung Circ"},{"key":"2024052816272982500_zuae014-B73","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B74","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT registry of transcatheter aortic valve replacement","volume":"76","author":"Carroll","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCEP.113.000876","article-title":"Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation","volume":"7","author":"Lim","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024052816272982500_zuae014-B76","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jce.16157","article-title":"Myocardial injury and inflammation following pulsed-field ablation and very high-power short-duration ablation for atrial fibrillation","volume":"35","author":"Popa","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024052816272982500_zuae014-B77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17434440.2022.2106853","article-title":"Antithrombotic therapy after transcatheter aortic valve implantation","volume":"19","author":"Greco","year":"2022","journal-title":"Expert Rev Med Devices"},{"key":"2024052816272982500_zuae014-B78","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2010.11.060","article-title":"Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation","volume":"57","author":"Rodes-Cabau","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B79","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2015.08.881","article-title":"Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry","volume":"66","author":"Ribeiro","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B80","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jcin.2019.07.004","article-title":"Stroke after transcatheter aortic valve replacement: a multifactorial phenomenon","volume":"12","author":"Capodanno","year":"2019","journal-title":"JACC. Cardiovascular Interven"},{"key":"2024052816272982500_zuae014-B81","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/icr.2019.24","article-title":"Anticoagulation after transcatheter aortic valve implantation: current Status","volume":"15","author":"Greco","year":"2020","journal-title":"Interv Cardiol"},{"key":"2024052816272982500_zuae014-B82","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14779072.2019.1632189","article-title":"Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update","volume":"17","author":"Greco","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2024052816272982500_zuae014-B83","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.amjcard.2012.12.059","article-title":"Prevalence and effect of myocardial injury after transcatheter aortic valve replacement","volume":"111","author":"Barbash","year":"2013","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14779072.2021.1902806","article-title":"Differences in coronary artery disease and outcomes of percutaneous coronary intervention with drug-eluting stents in women and men","volume":"19","author":"Greco","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2024052816272982500_zuae014-B85","doi-asserted-by":"crossref","first-page":"e011889","DOI":"10.1161\/JAHA.118.011889","article-title":"Prognostically significant myocardial injury in patients undergoing transcatheter aortic valve replacement","volume":"8","author":"Sharma","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2024052816272982500_zuae014-B86","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.amjcard.2023.08.174","article-title":"Coronary artery disease and transcatheter aortic valve implantation: unanswered questions and puzzling pathways","volume":"206","author":"Greco","year":"2023","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4244\/EIJ-D-22-00958","article-title":"Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in Collaboration with the ESC Working Group on Cardiovascular Surgery","volume":"19","author":"Tarantini","year":"2023","journal-title":"EuroIntervention"},{"key":"2024052816272982500_zuae014-B88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2019.06.012","article-title":"Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review","volume":"74","author":"Faroux","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B89","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4244\/EIJ-D-23-00186","article-title":"Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation","volume":"19","author":"Rheude","year":"2023","journal-title":"EuroIntervention"},{"key":"2024052816272982500_zuae014-B90","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/CIRCULATIONAHA.117.030114","article-title":"Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization","volume":"137","author":"Puelacher","year":"2018","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B91","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/ALN.0000000000000113","article-title":"Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes","volume":"120","author":"Botto","year":"2014","journal-title":"Anesthesiology"},{"key":"2024052816272982500_zuae014-B92","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jama.2017.4360","article-title":"Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery","volume":"317","author":"Writing Committee for the VISION Study Investigators","year":"2017","journal-title":"JAMA"},{"key":"2024052816272982500_zuae014-B93","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2012.02.021","article-title":"Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous","volume":"222","author":"Gualandro","year":"2012","journal-title":"Atherosclerosis"},{"key":"2024052816272982500_zuae014-B94","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ccd.23446","article-title":"Angiographic investigation of the pathophysiology of perioperative myocardial infarction","volume":"80","author":"Duvall","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B95","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jacc.2020.08.043","article-title":"Etiology of peri-operative myocardial infarction\/injury after noncardiac surgery and associated outcome","volume":"76","author":"Puelacher","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B96","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ehjacc\/zuaa008","article-title":"Incidence of major adverse cardiac events following non-cardiac surgery","volume":"10","author":"Sazgary","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2024052816272982500_zuae014-B97","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/eurheartj\/ehac798","article-title":"Long-term outcomes of perioperative myocardial infarction\/injury after non-cardiac surgery","volume":"44","author":"Puelacher","year":"2023","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B98","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1097\/SLA.0000000000005975","article-title":"Myocardial injury after noncardiac surgery in Major general surgical patients A prospective observational cohort study","volume":"278","author":"Jacka","year":"2023","journal-title":"Ann Surg"},{"key":"2024052816272982500_zuae014-B99","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/S0140-6736(18)30832-8","article-title":"Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial","volume":"391","author":"Devereaux","year":"2018","journal-title":"Lancet"},{"key":"2024052816272982500_zuae014-B100","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","article-title":"Five-Year outcomes after PCI or CABG for left main coronary disease","volume":"381","author":"Stone","year":"2019","journal-title":"N Engl J Med"},{"key":"2024052816272982500_zuae014-B101","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N Engl J Med"},{"key":"2024052816272982500_zuae014-B102","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N Engl J Med"},{"key":"2024052816272982500_zuae014-B103","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/CIRCULATIONAHA.115.020829","article-title":"Consistent reduction in periprocedural myocardial infarction with cangrelor as assessed by multiple definitions: findings from CHAMPION PHOENIX (cangrelor versus standard therapy to achieve optimal management of platelet inhibition)","volume":"134","author":"Cavender","year":"2016","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B104","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2020.08.009","article-title":"Impact of peri-procedural myocardial infarction on outcomes after revascularization","volume":"76","author":"Hara","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B105","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.120.047987","article-title":"Myocardial infarction in the ISCHEMIA trial","volume":"143","author":"Chaitman","year":"2021","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B106","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jacc.2020.08.024","article-title":"Procedural myocardial infarction: definitions everywhere, but not any that may fit","volume":"76","author":"Cutlip","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B107","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.2017.17488","article-title":"Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome","volume":"318","author":"Chapman","year":"2017","journal-title":"JAMA"},{"key":"2024052816272982500_zuae014-B108","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","article-title":"High-sensitivity assays for troponin in patients with cardiac disease","volume":"14","author":"Westermann","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2024052816272982500_zuae014-B109","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","article-title":"Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T","volume":"58","author":"Jaffe","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024052816272982500_zuae014-B110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1373\/clinchem.2011.166165","article-title":"Counterpoint: standardization of cardiac troponin I assays will not occur in my lifetime","volume":"58","author":"Apple","year":"2012","journal-title":"Clin Chem"},{"key":"2024052816272982500_zuae014-B111","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1093\/eurheartj\/ehad447","article-title":"Accelerated -Rule-Out of acute myocardial infarction using prehospital copeptin and in-hospital troponin: the AROMI study","volume":"44","author":"Pedersen","year":"2023","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408363.2023.2235426","article-title":"Establishing optimal cutoff values for high-sensitivity cardiac troponin algorithms in risk stratification of acute myocardial infarction","volume":"61","author":"Liu","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2024052816272982500_zuae014-B113","doi-asserted-by":"crossref","first-page":"e006752","DOI":"10.1161\/CIRCINTERVENTIONS.118.006752","article-title":"Prognostic impact of periprocedural myocardial infarction in patients undergoing elective percutaneous coronary interventions","volume":"11","author":"Koskinas","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B114","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/eurheartj\/ehab808","article-title":"Appropriate criteria for the definition of type 4a MI","volume":"43","author":"Silvain","year":"2022","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B115","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.1324","article-title":"Incidence and prediction of periprocedural myocardial infarction in elective PCI: the ALPHEUS-MI sub-study","volume":"44","author":"Montalescot","year":"2023","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B116","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.2190","article-title":"Appropriate ischemic criteria for type 4a myocardial infarction: insights from the ALPHEUS trial","volume":"44","author":"Roule","year":"2023","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B117","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2023.04.036","article-title":"Eligibility to intensified antithrombotic regimens for secondary prevention in patients who underwent percutaneous coronary intervention","volume":"199","author":"Greco","year":"2023","journal-title":"Am J Cardiol"},{"key":"2024052816272982500_zuae014-B118","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17425255.2023.2272595","article-title":"Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administration","volume":"19","author":"Spagnolo","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2024052816272982500_zuae014-B119","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.123.064473","article-title":"Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the academic research consortium","volume":"147","author":"Capodanno","year":"2023","journal-title":"Circulation"},{"key":"2024052816272982500_zuae014-B120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jacasi.2022.10.008","article-title":"Shortening dual antiplatelet therapy duration in high-risk patients undergoing percutaneous coronary intervention","volume":"3","author":"Greco","year":"2023","journal-title":"JACC Asia"},{"key":"2024052816272982500_zuae014-B121","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/eurheartj\/ehac713","article-title":"Dual antiplatelet therapy in patients at high bleeding risk: less is more-more or less","volume":"44","author":"Capodanno","year":"2023","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B122","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jcin.2023.08.037","article-title":"Short dual antiplatelet therapy in high bleeding risk patients: 1 month or 3 months?","volume":"16","author":"Capodanno","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B123","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/eurheartj\/ehad362","article-title":"Personalised antiplatelet therapies for coronary artery disease: what the future holds","volume":"44:","author":"Capodanno","year":"2023","journal-title":"Eur Heart J"},{"key":"2024052816272982500_zuae014-B124","first-page":"31","article-title":"P2y(12) inhibitor loading time before elective PCI and the prevention of myocardial necrosis","volume":"40","author":"Roule","year":"2024","journal-title":"Can J Cardiol"},{"key":"2024052816272982500_zuae014-B125","doi-asserted-by":"crossref","first-page":"e008649","DOI":"10.1161\/CIRCINTERVENTIONS.119.008649","article-title":"Randomized comparison of intensified and standard P2Y(12)-receptor-inhibition before elective percutaneous coronary intervention: the SASSICAIA trial","volume":"13","author":"Mehilli","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2024052816272982500_zuae014-B126","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(20)32236-4","article-title":"Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial","volume":"396","author":"Silvain","year":"2020","journal-title":"Lancet"},{"key":"2024052816272982500_zuae014-B127","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/14656566.2023.2171788","article-title":"Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"24","author":"Greco","year":"2023","journal-title":"Expert Opin Pharmacother"},{"key":"2024052816272982500_zuae014-B128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.31083\/j.rcm2310348","article-title":"P2y12 inhibitor monotherapy: considerations for acute and long-term secondary prevention post-PCI","volume":"23","author":"Greco","year":"2022","journal-title":"Rev Cardiovasc Med"}],"container-title":["European Heart Journal: Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuae014\/56914273\/zuae014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/13\/5\/433\/57953469\/zuae014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/13\/5\/433\/57953469\/zuae014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T15:18:36Z","timestamp":1731251916000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/13\/5\/433\/7602439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":128,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,2,7]]},"published-print":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuae014","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,2,7]]}}}